Kristina M. Leslie - 23 May 2025 Form 4 Insider Report for Hinge Health, Inc. (HNGE)

Reporting relationship: Director
Issuer ticker: HNGE
Reported as of: 23 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 May 2025, 17:30:02 UTC
Prior SEC filing: 21 May 2025
Next SEC filing: 19 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ David Wood, Attorney-in-Fact

Filing notes and source

Key filing fact

Kristina M. Leslie filed Form 4 for Hinge Health, Inc. (HNGE) on 23 May 2025.

Key facts

This page summarizes Kristina M. Leslie's Form 4 filing for Hinge Health, Inc. (HNGE).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 23 May 2025, 17:30.

Change

Previous filing in this sequence was filed on 21 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001307207 Primary reporting owner

Leslie Kristina M

Relationship: Director
Address: C/O HINGE HEALTH, INC., 455 MARKET STREET, SUITE 700, SAN FRANCISCO
Signature: /s/ David Wood, Attorney-in-Fact
Signature date: 23 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HNGE transaction

Common Stock

Other

Transaction value
Shares: -35,000
Change %: -100%
Price
Shares after: 0
Date: 23 May 2025
Ownership: Direct
Footnotes: F1

HNGE transaction

Class A Common Stock

Other

Transaction value
Shares: +35,000
Change %
Price
Shares after: 35,000
Date: 23 May 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Immediately prior to the completion of the Issuer's initial public offering, each share of Common Stock, other than those held by the Issuer's founders and certain related individuals, including shares of Common Stock underlying restricted stock unit ("RSU") awards, was reclassified into one share of Class A Common Stock in an exempt transaction pursuant to Rule 16b-7.

Footnote F2

Includes 26,250 RSUs, which vest in accordance with the terms of the award. Each RSU represents a contingent right to receive one share of Class A Common Stock.